India Globalization CapitalNYSE American: IGC

India Globalization Capital, Inc. purchases and resells physical infrastructure commodities. It operates through two segments, Infrastructure and Life Sciences. The company rents heavy construction equipment, including motor grader and rollers; and undertakes highway construction contracts. It also develops cannabinoid-based products and therapies, such as hemp-based tinctures to treat anxiety, and enhance the lifestyle of patients suffering from Alzheimer's under the Hyalolex brand name; CBD based tinctures, capsules, and topical analgesic creams to treat pain under the Holief brand name; CBD powered beauty and skincare products under the Herbo brand name; and CBD infused beverages under the Sunday Seltzer brand. The company also engages in the wholesale of hemp extract under the Holi Hemp brand; production of products, such as lotions, creams, and oils, as well as white labeling support services; and extraction and distillation of crude oil into hemp extracts. It operates in the United States, India, Colombia, and Hong Kong. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.

India Globalization Capital is in the Healthcare sector

India Globalization Capital is in the Biotechnology industry

India Globalization Capital is headquartered in United States

India Globalization Capital initial public offering (IPO) was on 24 May 2006

https://www.igcinc.us

No, India Globalization Capital is not included in the S&P 500 index

No, India Globalization Capital is not included in the NASDAQ 100 index

No, India Globalization Capital is not included in the Dow Jones index